Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic

Bibliographic Details
Main Authors:	McGregor, CG, Adams, A, Sadler, R, Arancibia-Cárcamo, CV, Palmer, R, Ambrose, T, Brain, O, Walsh, A, Klenerman, P, Travis, SP, Croft, NM, Lindsay, JO, Satsangi, J
Format:	Journal article
Language:	English
Published:	BMJ Publishing Group 2021

Similar Items